This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Diagnosis

Authoring team

Diagnosis is based upon clinical and biochemical features. A commonly used set of diagnostic criteria are those published by Gurd. Gurd produced lists of major and minor criteria. For the diagnosis of FES to be made at least one major and four minor criteria must be present.

Major criteria include:

  • axillary or subconjunctival petechiae
  • hypoxemia (PaO2 < 60 mmHg; FiO2 = 0.4)
  • central nervous system depression disproportionate to hypoxemia
  • pulmonary oedema

Minor criteria include:

  • tachycardia greater than 110 bpm
  • pyrexia greater than 38.5 degrees C
  • emboli present in the retina on fundoscopy
  • fat present in urine
  • a sudden inexplicable drop in haematocrit or platelet values
  • increasing ESR
  • fat globules present in the sputum

Gurd's criteria have been questioned however, and Murray and Racz suggested that tachycardia, tachypnoea, pyrexia and CNS involvement in the presence of arterial hypoxemia (PaO2 < 7.0 KPa) were better indicators. More recently, a fat embolism index has been proposed as a semiquantitative means of diagnosing FES in which each of seven clinical features is given a particular score. A score of more than 5 is required for a positive diagnosis.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.